The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer.
 
Andrés J. Muñoz Martín
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; Celgene; Daiichi Sankyo; Incyte; LEO Pharma; Lilly; MSD Oncology; Roche; Sanofi
Speakers' Bureau - Bayer; Menarini; Rovi; SERVIER
Research Funding - Celgene; LEO Pharma; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Amgen; Celgene; Merck Serono; Roche
 
Laura Ortega Morán
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Amgen; Leo Pharma; Merck Serono; Sanofi
 
Natalia Gutiérrez Alonso
No Relationships to Disclose
 
Diego Megias
No Relationships to Disclose
 
Ana Lopez-Alfonso
Consulting or Advisory Role - Amgen; SERVIER
Speakers' Bureau - Roche; SERVIER
 
Maria del Monte Millán
No Relationships to Disclose
 
Rebeca Bernat
No Relationships to Disclose
 
Rocío Martín Lozano
No Relationships to Disclose
 
Roberto Jiménez Rodríguez
No Relationships to Disclose
 
Irene Gonzalez Caraballo
No Relationships to Disclose
 
Lucía Villarejo López
No Relationships to Disclose
 
Tatiana Massarrah
Consulting or Advisory Role - AstraZeneca; Novartis; Novartis; Roche; Spanish Association of Medical Oncology (SEOM)
Speakers' Bureau - Roche
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Methods for selecting, manipuling and isolating circulating tumor cells in body fluids by lasser-assisted transfer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Novartis
 
Gabriela Torres Pérez-Solero
Speakers' Bureau - Advanced Accelerator Applications; Amgen; Ipsen; Lilly; Merck Serono; Pfizer; Roche; ROVI; Sanofi
 
Aitana Calvo Ferrándiz
Consulting or Advisory Role - Lilly; Merck
Expert Testimony - Amgen; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - Merck
 
Montserrat Blanco-Codesido
No Relationships to Disclose
 
Pilar Garcia-Alfonso
Consulting or Advisory Role - Amgen; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - Amgen; Merck Serono; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Other Relationship - Novartis; Roche